Astellas stem cells

Brief update from Bob Lanza on Astellas stem cell program

Lanza-Astellas

Late in 2015, one of the pioneering stem cell and regenerative medicine biotechs, Ocata Therapeutics (fka as ACT or Advanced Cell Technology) was acquired by Astellas Pharma. At the time of purchase, Ocata had a number of areas of focus, but was most closely followed for its development of human embryonic stem cell-based retinal pigmented epithelial …

Brief update from Bob Lanza on Astellas stem cell program Read More »